Search Results - "Laviste, G."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    186 Using electronic patient records as an effective tool to screen and improve recruitment to a Phase 1 trial in non-small cell lung cancer

    186 Using electronic patient records as an effective tool to screen and improve recruitment to a Phase 1 trial in non-small cell lung cancer by Haslett, K, Ashcroft, L, Bramley, R, Wilson, B, Livsey, J, Asselin, M, Bayman, N, Burt, P, Chan, C, Coote, J, Falk, S, Harris, M, Jackson, A, Laviste, G, Lee, L, Pemberton, L, Sheikh, H, Blackhall, F, Faivre-Finn, C

    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    1337P The clincial utility of circulating free DNA (cfDNA) analysis in non-small cell lung cancer (NSCLC) in the United Kingdom

    1337P The clincial utility of circulating free DNA (cfDNA) analysis in non-small cell lung cancer (NSCLC) in the United Kingdom by Greystoke, A., Carter, M., Griffiths, W., Laviste, G., Ortega-Franco, A., Rafee, S., Hannaway, N., Bridgewood, A., Hall, S., Blackhall, F.H.

    Published in Annals of oncology (01-09-2020)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    A phase I dose escalation study of the tolerability of the oral VEGFR and EGFR inhibitor vandetanib in combination with the oral MEK1/2 inhibitor selumetinib in solid tumors

    A phase I dose escalation study of the tolerability of the oral VEGFR and EGFR inhibitor vandetanib in combination with the oral MEK1/2 inhibitor selumetinib in solid tumors by Pacey, S., Blackhall, F., Garcia-Corbacho, J., Lipplaa, A., Fusi, A., Kumar, S., Hategan, M., Derham, J., Laviste, G., Halford, S., Foxton, C., McLeod, R., Wan, S., Talbot, D.

    Published in Annals of oncology (01-10-2016)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: